The growth of teledermatology: Expanding to reach the underserved

Chuchvara, Nadiya; Patel, Rachel; Srivastava, Radhika; Reilly, Catherine; Rao, Babar

doi:10.1016/j.jaad.2019.11.055

Cited by 43 publications

(41 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…14 By practicing teletriage, which prioritizes inperson clinic visits for patients with conditions associated with greater morbidity or mortality and uses telemedicine for the rest, the delivery of dermatologic care can be pursued during the pandemic. [15][16][17][18][19] Uncertainties about biologic and targeted therapies…”

Section: Shrinking Of Face-to-face Consultations and New Role For Telmentioning

confidence: 99%

“…All rights reserved In this situation, remote working is boosted, and telemedicine -that is defined as ''the remote diagnosis and treatment of patients by means of telecommunications technology'' -could be very appropriate [14]. By practicing teletriage, which prioritizes in-person clinic visits for patients with conditions associated with greater morbidity or mortality and uses telemedicine for the rest, the delivery of dermatologic care can be pursued during the pandemic [15][16][17][18].…”

Section: Accepted Articlementioning

confidence: 99%

See 1 more Smart Citation

Dermatologists and SARS‐CoV‐2: the impact of the pandemic on daily practice

Gisondi

Piaserico

Conti

et al. 2020

Acad Dermatol Venereol

103

View full text Add to dashboard Cite

Since the first case of 'pneumonia of unknown aetiology' was diagnosed at the Wuhan Jinyintan Hospital in China on 30 December 2019, what was recognized thereafter as 'severe acute respiratory syndrome coronavirus 2' (SARS-CoV-2) has spread over the four continents, causing the respiratory manifestations of coronavirus disease-19 (COVID-19) and satisfying the epidemiological criteria for a label of 'pandemic'. The ongoing SARS-CoV-2 pandemic is having a huge impact on dermatological practice including the marked reduction of face-to-face consultations in favour of teledermatology, the uncertainties concerning the outcome of COVID-19 infection in patients with common inflammatory disorders such as psoriasis or atopic dermatitis receiving immunosuppressive/immunomodulating systemic therapies; the direct involvement of dermatologists in COVID-19 care for patient assistance and new research needs to be addressed. It is not known yet if skin lesions and derangement of the skin barrier could make it easier for SARS-CoV-2 to transmit via indirect contact; it remains to be defined if specific mucosal or skin lesions are associated with SARS-CoV-2 infection, although some unpublished observations indicate the occurrence of a transient varicelliform exanthema during the early phase of the infection. SARS-CoV-2 is a new pathogen for humans that is highly contagious, can spread quickly, and is capable of causing enormous health, economic and societal impacts in any setting. The consequences may continue long after the pandemic resolves, and new management modalities for dermatology may originate from the COVID-19 disaster. Learning from experience may help to cope with future major societal changes.

show abstract

Section: Shrinking Of Face-to-face Consultations and New Role For Telmentioning

confidence: 99%

Section: Accepted Articlementioning

confidence: 99%

Dermatologists and SARS‐CoV‐2: the impact of the pandemic on daily practice

Gisondi

Piaserico

Conti

et al. 2020

Acad Dermatol Venereol

103

View full text Add to dashboard Cite

show abstract

“…In the Netherlands and some states of the United States, teledermatology is integrated into the health care system under full reimbursement. It has been reported that reimbursement has a favorable impact on the number of teleconsultations 17,18 . Reimbursement challenges seem to play a very important role in telemedicine expansion under current circumstances.…”

Section: Discussionmentioning

confidence: 99%

Investigating the factors enabling the accurate implementation of the patient‐assisted teledermatology model during the pandemic in Turkey: A pilot study

Turan

Utlu

2021

Dermatologic Therapy

View full text Add to dashboard Cite

We aim to investigate the factors enabling the accurate implementation of the patient-assisted teledermatology model during the pandemic in our country. This single-center, a prospective-survey study was enrolled consecutively 468 patients aged 13 years and older. The patients were asked about their attitudes towards teledermatology. After the dermatological examinations, the diagnosis and management of the diseases, and classification of diseases according to lesion locations were recorded. The physician's and the patient's opinions on whether it was possible to manage properly the current medical condition through teledermatology were recorded. The patients stated that 81.2% have been keen to use teledermatology for any complaints during the pandemic. 53.7% of the patients who are positive to use teledermatology expressed that they would never use this method unless it is fully reimbursed. Although it was thought that 49.8% of the current complaints according to the patients and 56.6% to the dermatologists could be resolved appropriately by teledermatology, for 24.8% either the patient's or the physician's opinion was contrary. Being woman, high-income level, and the presence of facial dermatosis favorably affected the patients' and physicians' evaluations regarding the suitability of the complaint to teledermatology. Factors such as low education level, insufficient technical skills to be examined alone, and the necessity of undressing for examination caused patients to consider teledermatology unsuitable for their current complaints.Priority should be given to the development of an appropriate reimbursement system and reducing potential medicolegal risks to encourage patients to participate in highquality teledermatology.

show abstract

“…Hence, due to its accessibility, equity, and cost efficiency, TD holds a bright future even in the developing parts of the world and will reduce the burden of in-person consultation for minor illnesses. [ 17 18 ]…”

Section: Discussionmentioning

confidence: 99%